Concepedia

Julia M. Adam

JM

Statistics

Publications

8

Citations

436

H-Index

8

Active since

2002

Affiliations

Merck Serono Ltd. (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Strathclyde

NHS Lanarkshire

Heriot-Watt University

Julia M. Adam is an author at Merck Serono Ltd. (United Kingdom) specializing in pharmacology, ligand binding, and medicinal chemistry.

Publications per year

2002–2019

8

Publications

8

Cyclodextrin-Derived Host Molecules as Reversal Agents for the Neuromuscular Blocker Rocuronium Bromide:  Synthesis and Structure−Activity Relationships

Julia M. Adam, David Jonathan Bennett, A. Bom et al. · Journal of Medicinal Chemistry · 2002 · 233 citations

, , +15

Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases

Faisa Omar, Jane E. Findlay, Gemma Carfray et al. · Proceedings of the National Academy of Sciences · 2019 · 80 citations · Full text

, , +17

Design, synthesis, and structure–activity relationships of indole-3-carboxamides as novel water soluble cannabinoid CB1 receptor agonists

Julia M. Adam, Jim Cairns, Wilson Caulfield et al. · MedChemComm · 2010 · 36 citations

, , +17

Design, synthesis, and structure–activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists

Elizabeth M. Moir, Kazuya Yoshiizumi, Jim Cairns et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 20 citations · Full text

, , +12

Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain

Julia M. Adam, John K. Clark, Keneth Davies et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 17 citations · Full text

, , +12

1–5 of 8